tiprankstipranks
Trending News
More News >
Heidelberg Pharma AG (GB:0QW5)
:0QW5
UK Market

Heidelberg Pharma AG (0QW5) Income Statement

Compare
0 Followers

Heidelberg Pharma AG Income Statement

Last quarter (Q1 2025), Heidelberg Pharma AG's total revenue was €1.27M, an increase of 0.27% from the same quarter last year. In Q1, Heidelberg Pharma AG's net income was €-5.94M. See Heidelberg Pharma AG’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 6.85M€ 9.86M€ 18.51M€ 1.75M€ 8.49M
Gross Profit
€ 4.20M€ 6.61M€ 13.83M€ -2.96M€ 2.89M
Operating Expenses
€ 28.76M€ 27.82M€ 32.17M€ 22.83M€ 21.45M
Depreciation and Amortization
€ 871.22K€ 879.00K€ 756.58K€ 802.86K€ 734.00K
EBITDA
€ -18.37M€ -18.71M€ -16.19M€ -24.83M€ -17.55M
Operating Income
€ -24.56M€ -21.21M€ -18.33M€ -25.63M€ -18.56M
Other Income/Expenses
€ 5.18M€ 863.31K€ -604.67K€ -507.64K€ -84.32K
Pretax Income
€ -19.38M€ -20.35M€ -17.79M€ -26.14M€ -18.37M
Net Income
€ -19.38M€ -20.35M€ -19.70M€ -26.63M€ -18.37M
Per Share Metrics
Basic EPS
€ -0.42€ -0.44€ -0.53€ -0.82€ -0.61
Diluted EPS
€ -0.42€ -0.44€ -0.53€ -0.82€ -0.61
Weighted Average Shares Outstanding
46.60M 46.60M 37.24M 32.50M 29.90M
Weighted Average Shares Outstanding (Diluted)
46.60M 46.60M 37.24M 32.50M 29.90M
Currency in EUR

Heidelberg Pharma AG Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis